封面
市场调查报告书
商品编码
1751240

动物输液解决方案市场规模、份额、趋势分析报告:按产品、动物种类、适应症、最终用途、地区、细分市场预测,2025-2030 年

Veterinary Intravenous Solutions Market Size, Share & Trends Analysis Report By Product, By Animal Type (Companion Animals, Production Animals), By Indication, By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

动物输液解决方案市场的成长与趋势:

根据 Grand View Research, Inc. 的最新报告,全球兽医输液解决方案市场规模预计到 2030 年将达到 20.7 亿美元,2025 年至 2030 年期间的复合年增长率为 6.21%。

这一增长的驱动力源于动物福利意识的提升、兽医学的进步、宠物主人数量的增加以及炭疽病、胰臟炎、口蹄疫等疾病的增加。兽医学的进步扩大了动物治疗的选择。兽医医院和诊所配备了输液系统等先进的诊断和治疗设备,这促进了市场的成长。

专为兽医设计的先进输液系统的开发,使给药过程更有效率、准确和安全。这些技术进步,例如专用输液帮浦和输液监测系统,正在透过改善患者照护和降低併发症风险,对兽医输液解决方案产业产生积极影响。许多地区可支配收入水准的提高,导致宠物医疗保健支出增加。宠物饲主更愿意投资于高品质的兽医护理,包括输液治疗,从而促进了市场的成长。

由于全球疫情持续演变,新冠疫情对兽医输液产业的影响尚待确定。新冠疫情的復苏导致兽医静脉输液的需求增加,静脉输液是动物手术、治疗和严重监护期间的标准护理之一。疫情的经济影响波及了许多个人和企业,包括宠物饲主和兽医诊所。经济限制可能影响了宠物饲主的决策流程,导致非必要的兽医程序和治疗(包括输液)减少。

此外,北美兽医液体疗法的采用率相对较高,这得益于多种因素,包括北美的兽医教育计画强调液体疗法的重要性及其在各种临床情况下的合理应用;兽医和兽医技术人员接受了关于液体给药、监测和管理的全面培训,并实践了液体的合理使用;北美的兽医专业人员致力于为动物提供高品质的护理。液体疗法是综合兽医护理的重要组成部分,其采用源于对优化患者照护和支持动物康復与健康的承诺。

动物输液市场报告重点

  • 按产品划分,等渗晶体部分将在 2024 年占据市场主导地位,份额超过 42.00%。等渗透压晶体常用于兽医输液治疗,以恢復和维持动物的水合和电解质平衡。
  • 从动物类型来看,伴侣动物在2024年占据了市场主导地位。许多家庭定期饲养伴侣动物作为宠物,尤其是狗和猫。宠物饲养导致对兽医液体的需求庞大,因为这些动物通常需要输液治疗各种健康问题、手术和严重治疗。
  • 根据适应症,糖尿病酮酸症领域占据兽医静脉注射溶液市场的主导地位,2024 年的收入份额超过 28.0%。
  • 根据最终用途,预计到2024年,兽医院领域将占据最高的市场份额,因为越来越多的人将宠物带到兽医院。静脉补液疗法在兽医院经常使用,是患者照护的重要组成部分。
  • 到 2024 年,北美将占据市场的最高收益占有率,超过 38.09%。北美的宠物拥有率很高,许多家庭饲养狗、猫和小型哺乳动物等伴侣动物。

目录

第一章调查方法与范围

第二章执行摘要

第三章:动物输液解决方案市场的趋势与展望

  • 市场展望
    • 母市场
    • 补贴市场
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 动物输液解决方案市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 法律规范
    • 定价分析
    • 製造、需求和供应链分析
    • 以主要国家和物种估计的动物数量(2024 年)

第四章动物输液溶液市场:依动物种类的估计与趋势分析

  • 细分仪表板
  • 动物输液解决方案市场:动物种类差异分析
  • 动物输液解决方案市场规模和趋势分析(按动物类型,2018-2030 年)
    • 生产动物
    • 伴侣动物

第五章动物输液解决方案市场:按产品分類的估计和趋势分析

  • 细分仪表板
  • 动物输液解决方案市场:依产品进行的变化分析
  • 动物输液解决方案市场规模与趋势分析(按产品,2018-2030 年)
    • 等渗晶体溶液
    • 合成胶体
    • 血液製品
    • 葡萄糖溶液
    • 经肠营养

第六章动物输液溶液市场:依适应症的估计与趋势分析

  • 细分仪表板
  • 动物输液解决方案市场:依适应症进行的变化分析
  • 动物输液解决方案市场规模与趋势分析(按适应症)(2018-2030 年)
    • 糖尿病酮酸症
    • 胰臟炎
    • 炭疽菌
    • 慢性肾臟病
    • 其他的

第七章动物输液溶液市场:依最终用途的估计和趋势分析

  • 细分仪表板
  • 动物输液解决方案市场:以最终用途进行的变化分析
  • 动物输液解决方案市场规模和趋势分析(按最终用途)(2018-2030 年)
    • 兽医诊所
    • 研究机构
    • 其他的

第 8 章:动物输液解决方案市场:区域估计和趋势分析

  • 区域仪表板
  • 2024 年及 2030 年动物输液解决方案市场占有率(按地区)
  • 区域展望
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 市场参与企业分类
  • 企业市场分析/堆图分析
  • 公司简介
    • Merck &Co., Inc
    • Dechra.
    • Animalcare Limited
    • Elanco Animal Health Incorporated
    • Zoetis
    • Scopio B. Braun Vet Care(B Braun SE)
  • 战略地图
    • 合併与收购
    • 伙伴关係和合作
    • 产品发布
    • 其他的
  • 其他主要角色列表
Product Code: GVR-4-68040-099-7

Veterinary Intravenous Solutions Market Growth & Trends:

The global veterinary intravenous solutions market size is estimated to reach USD 2.07 billion by 2030, expanding at a CAGR of 6.21% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth is driven by increasing awareness of animal welfare, advancements in veterinary healthcare, increasing pet ownership, and the increasing prevalence of illnesses such as anthrax, pancreatitis, and mouth disease. The advancements in veterinary medicine have expanded the range of treatment options available for animals. Veterinary clinics and hospitals are equipped with advanced diagnostic and treatment facilities, including intravenous fluid administration systems, which contribute to the growth of the market.

The development of advanced IV fluid delivery systems designed specifically for veterinary use has made the administration process more efficient, accurate, and safe. These technological advancements, such as specialized infusion pumps and fluid monitoring systems, have positively impacted the veterinary intravenous solutions industry by enhancing patient care and reducing the risk of complications. Rising disposable income levels in many regions have led to increased spending on pet healthcare. Pet owners are more willing to invest in high-quality veterinary care, including intravenous fluid therapy, which contributes to the growth of the market.

The post-COVID-19 impact on the veterinary intravenous solutions industry is still unfolding as the global situation continues to evolve. The COVID-19 pandemic recovery has led to an increased demand for veterinary intravenous solutions as part of the standard care provided to animals during surgeries, treatments, and critical care situations. The economic impact of the pandemic affected many individuals and businesses, including pet owners and veterinary clinics. Financial constraints may have influenced the decision-making process for pet owners, potentially leading to a decrease in non-essential veterinary procedures and treatments, including the use of IV fluids.

Moreover, the adoption of veterinary intravenous (IV) fluid solutions in North America is relatively high due to various factors such as veterinary education programs in North America emphasizing the importance of IV fluid therapy and its appropriate use in different clinical situations. Veterinarians and veterinary technicians receive extensive training in the administration, monitoring, and management of IV fluids, ensuring their competent use in practice. Furthermore, veterinary professionals in North America strive to provide high-quality care for animals. IV fluid therapy is a crucial component of comprehensive veterinary treatment, and its adoption is driven by the commitment to optimize patient care and support the recovery and well-being of animals.

Veterinary Intravenous Solutions Market Report Highlights:

  • Based on product, the isotonic crystalloids segment dominated the market with a share of over 42.00% in 2024. To restore and maintain hydration and electrolyte balance in animals, fluid therapy in veterinary medicine frequently uses isotonic crystalloid solutions
  • Based on animal type, the companion animals segment dominated the market in 2024. Many homes regularly keep companion animals as pets, especially dogs and cats. Pet ownership leads to a large demand for veterinary intravenous solutions, as these animals frequently require intravenous therapy for a variety of health issues, surgeries, or critical care situations
  • Based on indication, the diabetic ketoacidosis segment dominated the market for veterinary intravenous (IV) solutions with a revenue share of over 28.0% in 2024.
  • Based on end-use, the veterinary hospital segment accounted for the highest share in the market 2024, as more people are taking their pets to veterinarian facilities for care. IV hydration therapy is frequently used in veterinary hospitals as a crucial part of patient care
  • North America held the highest revenue share of over 38.09% of the market in 2024. In North America, there is a high rate of pet ownership, with many homes keeping companion animals like dogs, cats, and small mammals

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Intravenous (IV) Solutions Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Prevalence of Animal Disease and Dehydration
      • 3.2.1.2. Rising Uptake of Pet Insurance
      • 3.2.1.3. Increase in Pet Ownership and Pet Expenditure
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Risk of Infection and Complications
      • 3.2.2.2. Preference of Oral Alternatives
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Veterinary Intravenous (IV) Solutions Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Pricing Analysis
    • 3.3.5. Manufacturing, Demand, and Supply Chain Analysis
    • 3.3.6. Estimated Animal Population by key countries, key species, 2024

Chapter 4. Veterinary Intravenous (IV) Solutions Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary Intravenous (IV) Solutions Market: Animal Type Movement Analysis
  • 4.3. Veterinary Intravenous (IV) Solutions Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
  • 4.4. Production Animals
    • 4.4.1. Production Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Companion Animals
    • 4.5.1. Companion Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Intravenous (IV) Solutions Market: By Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary Intravenous (IV) Solutions Market: By Product Movement Analysis
  • 5.3. Veterinary Intravenous (IV) Solutions Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
    • 5.3.1. Isotonic crystalloids
      • 5.3.1.1. Isotonic crystalloids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Synthetic colloids
      • 5.3.2.1. Synthetic Colloids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Blood products
      • 5.3.3.1. Blood Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Dextrose solution
      • 5.3.4.1. Dextrose Solution Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Parenteral nutrition
      • 5.3.5.1. Parenteral Nutrition Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Intravenous (IV) Solutions Market: By Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary Intravenous (IV) Solutions Market: By Indication Movement Analysis
  • 6.3. Veterinary Intravenous (IV) Solutions Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
    • 6.3.1. Diabetic Ketoacidosis
      • 6.3.1.1. Diabetic Ketoacidosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Pancreatitis
      • 6.3.2.1. Pancreatitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Anthrax
      • 6.3.3.1. Anthrax Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Chronic Kidney Disease
      • 6.3.4.1. Chronic Kidney Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Others
      • 6.3.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Intravenous (IV) Solutions Market: By End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Veterinary Intravenous (IV) Solutions Market: By End Use Movement Analysis
  • 7.3. Veterinary Intravenous (IV) Solutions Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
    • 7.3.1. Veterinary Hospitals
      • 7.3.1.1. Veterinary Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. Research Institutes
      • 7.3.2.1. Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Others
      • 7.3.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Intravenous (IV) Solutions Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Veterinary Intravenous (IV) Solutions Market Share, By Region, 2024 & 2030 (USD Million)
  • 8.3. Regional Outlook
  • 8.4. North America
    • 8.4.1. North America Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. U.S. Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Canada Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Mexico Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. UK Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Germany Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. France Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Italy Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Spain Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Denmark Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Sweden Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Norway Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Japan Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. China Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. India Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Australia Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. South Korea Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Thailand Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Brazil Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Argentina Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Middle East & Africa
    • 8.8.1. Middle East & Africa Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. South Africa Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Saudi Arabia Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. UAE Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Kuwait Veterinary Intravenous (IV) Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Position Analysis/ Heap Map Analysis
  • 9.3. Company Profiles
    • 9.3.1. Merck & Co., Inc
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Dechra.
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Animalcare Limited
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Elanco Animal Health Incorporated
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Zoetis
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Scopio B. Braun Vet Care (B Braun SE)
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
  • 9.4. Strategy Mapping
    • 9.4.1. Mergers & Acquisitions
    • 9.4.2. Partnerships & Collaborations
    • 9.4.3. Product launch
    • 9.4.4. Others
  • 9.5. List of other key players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Veterinary Intravenous (IV) Solutions Market, by region, 2018 - 2030 (USD Million)
  • Table 3 Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 4 Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 5 Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 6 Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 7 North America Veterinary Intravenous (IV) Solutions Market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 9 North America Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 10 North America Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 North America Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 12 U.S. Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 14 U.S. Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 15 U.S. Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 16 Canada Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 17 Canada Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 18 Canada Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 19 Canada Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 20 Mexico Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 21 Mexico Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 22 Mexico Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Mexico Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 24 Europe Veterinary Intravenous (IV) Solutions Market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 26 Europe Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 27 Europe Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 28 Europe Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 29 Germany Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 30 Germany Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 31 Germany Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Germany Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 33 UK Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 34 UK Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 35 UK Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 36 UK Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 37 France Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 38 France Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 39 France Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 40 France Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 41 Italy Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 42 Italy Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 43 Italy Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 44 Italy Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 45 Spain Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 46 Spain Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 47 Spain Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 48 Spain Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 49 Denmark Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 50 Denmark Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 51 Denmark Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 Denmark Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 53 Sweden Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 54 Sweden Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 55 Sweden Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 56 Sweden Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 57 Norway Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 58 Norway Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 59 Norway Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 60 Norway Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Veterinary Intravenous (IV) Solutions Market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 66 China Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 67 China Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 68 China Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 69 China Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 70 Japan Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 71 Japan Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 72 Japan Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 73 Japan Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 74 India Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 75 India Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 76 India Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 India Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 78 South Korea Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 79 South Korea Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 80 South Korea Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 81 South Korea Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 82 Australia Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 83 Australia Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 84 Australia Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 85 Australia Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 86 Thailand Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 87 Thailand Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 88 Thailand Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 89 Thailand Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 90 Latin America Veterinary Intravenous (IV) Solutions Market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 92 Latin America Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 93 Latin America Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 94 Latin America Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 95 Brazil Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 96 Brazil Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 97 Brazil Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 98 Brazil Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 99 Argentina Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 100 Argentina Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 101 Argentina Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 102 Argentina Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 103 MEA Veterinary Intravenous (IV) Solutions Market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 105 MEA Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 106 MEA Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 107 MEA Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 108 South Africa Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 109 South Africa Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 110 South Africa Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 111 South Africa Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 116 UAE Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 117 UAE Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 118 UAE Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 119 UAE Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait Veterinary Intravenous (IV) Solutions Market, by Animal type, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Veterinary Intravenous (IV) Solutions Market, by Indication, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Veterinary Intravenous (IV) Solutions Market, by Product, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Veterinary Intravenous (IV) Solutions Market, by End use, 2018 - 2030 (USD Million)
  • Table 124 Company Overview
  • Table 125 Product Benchmarking
  • Table 126 Financial Performance
  • Table 127 Strategic Initiatives

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Veterinary Intravenous (IV) Solutions Market revenue, 2018 - 2030 (USD Million)
  • Fig. 10 Veterinary Intravenous (IV) Solutions Market snapshot
  • Fig. 11 Veterinary Intravenous (IV) Solutions Market driver impact
  • Fig. 12 Veterinary Intravenous (IV) Solutions Market restraint impact
  • Fig. 13 Veterinary Intravenous (IV) Solutions animal type key takeaways (USD Million)
  • Fig. 14 Veterinary Intravenous (IV) Solutions Market: animal Type movement analysis
  • Fig. 15 Companion animals market, 2018 - 2030 (USD Million)
  • Fig. 16 Production animals market, 2018 - 2030 (USD Million)
  • Fig. 17 Veterinary Intravenous (IV) Solutions Market Product key takeaways (USD Million)
  • Fig. 18 Veterinary Intravenous (IV) Solutions Market: product movement analysis
  • Fig. 19 Isotonic crystalloids market, 2018 - 2030 (USD Million)
  • Fig. 20 Synthetic colloids market, 2018 - 2030 (USD Million)
  • Fig. 21 Blood products market, 2018 - 2030 (USD Million)
  • Fig. 22 Dextrose Solution market, 2018 - 2030 (USD Million)
  • Fig. 23 Parenteral nutrition market, 2018 - 2030 (USD Million)
  • Fig. 24 Veterinary Intravenous (IV) Solutions Market Indication key takeaways (USD Million)
  • Fig. 25 Veterinary Intravenous (IV) Solutions Market: Indication movement analysis
  • Fig. 26 Diabetic Ketoacidosis market, 2018 - 2030 (USD Million)
  • Fig. 27 Pancreatitis market, 2018 - 2030 (USD Million)
  • Fig. 28 Anthrax market, 2018 - 2030 (USD Million)
  • Fig. 29 Chronic Kidney Disease market, 2018 - 2030 (USD Million)
  • Fig. 30 Others market, 2018 - 2030 (USD Million)
  • Fig. 31 Veterinary Intravenous (IV) Solutions Market by End Use key takeaways (USD Million)
  • Fig. 32 Veterinary Intravenous (IV) Solutions Market: by End Use movement analysis
  • Fig. 33 Veterinary Research Institutes market, 2018 - 2030 (USD Million)
  • Fig. 34 Veterinary Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 35 Research Institutes market, 2018 - 2030 (USD Million)
  • Fig. 36 Others market, 2018 - 2030 (USD Million)
  • Fig. 37 Regional market place: Key takeaways
  • Fig. 38 Regional outlook, 2024 & 2030
  • Fig. 39 North America Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 42 Mexico Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 44 UK Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 45 Germany Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 46 France Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 54 China Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 55 India Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 56 Australia Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 62 MEA Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 65 UAE Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 66 Kuwait Veterinary Intravenous (IV) Solutions Market, 2018 - 2030 (USD Million)
  • Fig. 67 Market participant categorization